Title:
COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2021/149663
Kind Code:
A1
Abstract:
The present invention provides a composition capable of promoting the growth of a bacterium of the genus Bifidobacterium that can act as a beneficial bacterium. This composition comprises a mixture of human milk oligosaccharides, said mixture consisting of lacto-N-neotetraose, lacto-N-tetraose, 2'-fucosyllactose, 3'-sialyllactose and 6'-sialyllactose, together with Bifidobacterium longum subspecies infantis.
Inventors:
HARA SAKIKO (JP)
ODAMAKI TOSHITAKA (JP)
ODAMAKI TOSHITAKA (JP)
Application Number:
PCT/JP2021/001603
Publication Date:
July 29, 2021
Filing Date:
January 19, 2021
Export Citation:
Assignee:
MORINAGA MILK INDUSTRY CO LTD (JP)
International Classes:
A23C9/152; A23L33/125; A23L33/135; C12N1/20
Domestic Patent References:
| WO2018181069A1 | 2018-10-04 |
Foreign References:
| JP2019218280A | 2019-12-26 |
Other References:
HORIGOME AYAKO, EHARA TATSUYA, ODAMAKI TOSHITAKA, SHIMIZU TAKASHI: "The Influence of Factors in Breast Milk and the Development of Infant Formula on Infant Gut Microbiota", JOURNAL OF INTESTINAL MICROBIOLOGY, vol. 33, 2019, pages 1 - 14, XP055843657
OZCAN, E. ET AL.: "Inefficient Metabolism of the Human Milk Oligosaccharides Lacto-N-tetraose and Lacto-N-neotetraose Shifts Bifidobacterium longum subsp. infant is Physiology", FRONT NUTR., vol. 5, no. 46, 2018, pages 1 - 18, XP055843661, Retrieved from the Internet [retrieved on 20210219]
KITAOKA, MOTOMITSU: "Molecular mechanism how human milk oligosaccharides stimulate intestinal growth of bifidobacterial", MILK SCIENCE, vol. 61, no. 2, 2012, pages 115 - 124, XP055843681
ANONYMOUS: "History of Changes for Study: NCT03994315 The EFFECT Study: Probiotic and HMO Supplementation in Infants (EFFECT)", CLINICALTRIALS.GOV ARCHIVE, 16 July 2019 (2019-07-16), pages 1 - 5, XP055843706, Retrieved from the Internet [retrieved on 20210219]
JAPANESE JOURNAL OF LACTIC ACID BACTERIA, vol. 22, no. 1, 2011, pages 5 - 25
MILK SCIENCE, vol. 56, no. 4, 2008, pages 155 - 176
MILK SCIENCE, vol. 61, no. 2, 2012
See also references of EP 4094582A4
OZCAN, E. ET AL.: "Inefficient Metabolism of the Human Milk Oligosaccharides Lacto-N-tetraose and Lacto-N-neotetraose Shifts Bifidobacterium longum subsp. infant is Physiology", FRONT NUTR., vol. 5, no. 46, 2018, pages 1 - 18, XP055843661, Retrieved from the Internet
KITAOKA, MOTOMITSU: "Molecular mechanism how human milk oligosaccharides stimulate intestinal growth of bifidobacterial", MILK SCIENCE, vol. 61, no. 2, 2012, pages 115 - 124, XP055843681
ANONYMOUS: "History of Changes for Study: NCT03994315 The EFFECT Study: Probiotic and HMO Supplementation in Infants (EFFECT)", CLINICALTRIALS.GOV ARCHIVE, 16 July 2019 (2019-07-16), pages 1 - 5, XP055843706, Retrieved from the Internet
JAPANESE JOURNAL OF LACTIC ACID BACTERIA, vol. 22, no. 1, 2011, pages 5 - 25
MILK SCIENCE, vol. 56, no. 4, 2008, pages 155 - 176
MILK SCIENCE, vol. 61, no. 2, 2012
See also references of EP 4094582A4
Attorney, Agent or Firm:
MATSUNUMA Yasushi et al. (JP)
Download PDF:
Previous Patent: HIGH-FREQUENCY TERMINATOR
Next Patent: CONTRAST MEDIUM INJECTION DEVICE AND INJECTION LINE KIT
Next Patent: CONTRAST MEDIUM INJECTION DEVICE AND INJECTION LINE KIT